RNF114 and breast cancer: Our current research showed that RNF114 is highly expressed in both BC tissues and established BC cell lines, and its elevated expression correlates with TNM stage and poor survival outcomes (Figure 1), which could be utilized as a novel biomarker for predicting BC patient outcomes.